Detalhe da pesquisa
1.
Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial.
Breast Cancer Res Treat;
202(1): 57-65, 2023 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37578666